Great Post 4 Seasons, I think Dendrion and ONTY are in pain because word is out PRR is building success day by day,PRR is the gorilla in the room, eventially competeing directly with their products, against PRRs other Mucin 1 receptive cancers plus CVAC's orphan status,there is talk of a takeover on DNDN? Why take over that one? $1.6 bill cap was over $5 b v $160 mill for PRR, that is an insult for what PRR has so far.
one way or the other, page-11
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.010(2.94%) |
Mkt cap ! $501.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 35.3¢ | 34.0¢ | $404.0K | 1.166M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 99168 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 56496 | 11 |
View Market Depth
| Last trade - 11.34am 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |